BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL

Vaccinations effectively prevent infections; however, patients with chronic lymphocytic leukemia (CLL) have reduced antibody responses following vaccinations. Combined humoral and cellular immune responses to novel adjuvanted vaccines are not well characterized in CLL. In an open-label, single-arm c...

Full description

Bibliographic Details
Main Authors: Ahn, I.E (Author), Ali, M.A (Author), Cohen, J.I (Author), Koelle, D.M (Author), Laing, K.J (Author), Lotter, J. (Author), Maddux, E. (Author), McClurkan, C.L (Author), Nierman, P. (Author), Pleyer, C. (Author), Soto, S. (Author), Sun, C. (Author), Superata, J. (Author), Tian, X. (Author), Wiestner, A. (Author)
Format: Article
Language:English
Published: American Society of Hematology 2022
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items